Table 4.5.

Development of orally administered therapeutic biological products which are in clinical phases

Company	Product	Clinical phase
Emisphere Technologies	Salmon calcitonin	Clinical phase III
Emisphere Technologies/Novo Nordisk	GLP-1 (glucagon-like peptide)	Clinical phase I
Emisphere Technologies/Novo Nordisk	Insulin	Clinical phase I
Biocon	IN-105 (insulin conjugate)	Clinical phase III (India)
		Clinical phase I (USA)
Fosse Bio-Engineering Development Ltd.	Insulin	Clinical phase III
Generex	Oral-lyn™ (buccal insulin spray)	Approved product for sale on the market in many countries. Experimental products in the United States